Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EEXNASDAQ:EGHTNYSE:EVHNASDAQ:NEO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEEXEmerald$4.69-3.9%$4.26$3.22▼$6.74$932.65M1.11195,774 shs108,718 shsEGHT8X8$1.74-3.9%$1.73$1.51▼$3.52$233.99M1.791.11 million shs1.22 million shsEVHEvolent Health$8.27-2.2%$8.96$7.06▼$33.63$970.31M0.872.41 million shs812,955 shsNEONeoGenomics$7.07-4.3%$8.22$6.08▼$19.12$909.87M1.651.21 million shs1.53 million shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEEXEmerald-0.31%+5.13%+4.74%+19.50%-21.86%EGHT8X80.00%+2.26%-6.22%-15.42%-28.74%EVHEvolent Health-2.18%+3.01%-8.95%-10.56%-63.57%NEONeoGenomics-5.62%+3.65%-11.60%-24.75%-47.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEEXEmerald1.4837 of 5 stars3.51.00.80.02.20.00.0EGHT8X84.3771 of 5 stars4.05.00.00.03.42.51.9EVHEvolent Health1.8409 of 5 stars3.51.00.00.03.30.00.6NEONeoGenomics3.8688 of 5 stars4.25.00.00.01.43.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEEXEmerald 3.00Buy$7.9065.79% UpsideEGHT8X8 2.00Hold$2.5141.65% UpsideEVHEvolent Health 3.00Buy$17.79110.51% UpsideNEONeoGenomics 2.45Hold$13.8390.52% UpsideCurrent Analyst Ratings BreakdownLatest EGHT, EVH, NEO, and EEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025EGHT8X8Weiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)5/24/2025EGHT8X8Weiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)5/20/2025EGHT8X8Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.70 ➝ $2.705/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral5/14/2025EGHT8X8B. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $3.005/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/10/2025EGHT8X8Weiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)5/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.005/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.005/2/2025EEXEmeraldRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.80 ➝ $7.805/1/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.00(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEEXEmerald$413.10M2.29$0.70 per share6.83($1.47) per share-3.24EGHT8X8$715.07M0.33$0.43 per share4.16$0.86 per share2.06EVHEvolent Health$2.40B0.41$1.41 per share6.00$9.38 per share0.90NEONeoGenomics$672.36M1.39$0.27 per share27.03$7.02 per share1.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEEXEmerald-$8.20M$0.03N/A∞N/A-5.29%-13.26%-1.92%8/5/2025 (Estimated)EGHT8X8-$67.59M-$0.21N/A17.756.08-6.33%-1.45%-0.21%N/AEVHEvolent Health-$113.04M-$1.23N/AN/AN/A-2.41%5.73%2.36%8/6/2025 (Estimated)NEONeoGenomics-$87.97M-$0.61N/A80.68N/A-11.92%-2.10%-1.17%8/4/2025 (Estimated)Latest EGHT, EVH, NEO, and EEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million5/1/2025Q1 2025EEXEmerald$0.07$0.08+$0.01$0.08$134.30 million$147.70 million4/29/2025Q1 2025NEONeoGenomics-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million3/14/2025Q4 2024EEXEmerald$0.03$0.03N/A$0.03$108.05 million$106.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEEXEmerald$0.061.26%N/A200.00%N/AEGHT8X8N/AN/AN/AN/AN/AEVHEvolent HealthN/AN/AN/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/ALatest EGHT, EVH, NEO, and EEX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025EEXEmeraldquarterly$0.01501.3%5/12/20255/12/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEEXEmerald1.021.271.27EGHT8X83.081.251.24EVHEvolent Health0.581.041.04NEONeoGenomics0.381.981.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEEXEmerald14.90%EGHT8X893.99%EVHEvolent HealthN/ANEONeoGenomics98.50%Insider OwnershipCompanyInsider OwnershipEEXEmerald4.00%EGHT8X81.22%EVHEvolent Health1.40%NEONeoGenomics2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEEXEmerald600198.86 million179.64 millionOptionableEGHT8X82,220134.48 million130.09 millionOptionableEVHEvolent Health5,100117.40 million114.70 millionOptionableNEONeoGenomics2,100128.70 million126.79 millionOptionableEGHT, EVH, NEO, and EEX HeadlinesRecent News About These CompaniesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 13 at 10:45 AM | accessnewswire.comNeoGenomics (NASDAQ:NEO) Stock Price Down 5.2% - Here's WhyJune 12 at 4:58 PM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 12 at 9:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 11 at 9:00 AM | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 9, 2025 | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 7, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 4, 2025 | accessnewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Short Interest Up 32.2% in MayJune 3, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 3, 2025 | accessnewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 1, 2025 | marketbeat.comNuveen Asset Management LLC Sells 98,179 Shares of NeoGenomics, Inc. (NASDAQ:NEO)June 1, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Director Michael Aaron Kelly Purchases 5,000 SharesMay 30, 2025 | marketbeat.comNeoGenomics unveils new oncology diagnostics at ASCO 2025May 29, 2025 | investing.comFort Myers-based NeoGenomics to unveil new cancer diagnostics at ASCO 2025May 29, 2025 | gulfshorebusiness.comNeoGenomics, Inc. (NASDAQ:NEO) Director Buys $38,000.00 in StockMay 29, 2025 | insidertrades.comNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025May 29, 2025 | finance.yahoo.comBNP Paribas Financial Markets Sells 35,979 Shares of NeoGenomics, Inc. (NASDAQ:NEO)May 26, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Hold" from AnalystsMay 26, 2025 | marketbeat.comNeoGenomics introduces c-MET companion diagnostic for NSCLCMay 23, 2025 | finance.yahoo.comNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung CancerMay 22, 2025 | businesswire.comNeoGenomics to Participate in Upcoming June Investor ConferencesMay 20, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEGHT, EVH, NEO, and EEX Company DescriptionsEmerald NYSE:EEX$4.69 -0.19 (-3.89%) Closing price 03:59 PM EasternExtended Trading$4.68 -0.01 (-0.21%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Emerald Holding, Inc. operates business-to-business (B2B) trade shows in the United States. The company provides B2B trade show franchises; and B2B print publications and digital media products, which provide industry specific business news and information across various sectors. It also offers B2B e-commerce and digital merchandising solutions to manufacturers and retailers through Elastic Suite and Bulletin platforms. The company serves retail, design, technology, equipment, and safety and security. Emerald Holding, Inc. was incorporated in 2013 and is headquartered in New York, New York.8X8 NASDAQ:EGHT$1.74 -0.07 (-3.87%) Closing price 04:00 PM EasternExtended Trading$1.74 0.00 (-0.29%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.8x8, Inc. engages in the provision of enterprise communication solutions. It offers solutions to the business services, education, financial services, government, healthcare, and manufacturing industries. The company was founded in February 1987 and is headquartered in Campbell, CA.Evolent Health NYSE:EVH$8.26 -0.19 (-2.19%) Closing price 03:59 PM EasternExtended Trading$8.27 +0.00 (+0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.NeoGenomics NASDAQ:NEO$7.07 -0.32 (-4.33%) Closing price 04:00 PM EasternExtended Trading$7.06 0.00 (-0.07%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
